Article
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study
Registro en:
CRUMP, J. A. et al. Predictors and Outcomes of Mycobacterium Tuberculosis Bacteremia among Patients with HIV and Tuberculosis Co-Infection Enrolled in the ACTG A5221 STRIDE Study. BMC Infectious Diseases, v. 15, p. 12, 2015
1471-2334
10.1186/s12879-014-0735-5
Autor
Crump, John A
Wu, Xingye
Kendall, Michelle A
Ive, Prudence D
Kumwenda, Johnstone J
Grinsztejn, Beatriz
Jentsch, Ute
Swindells, Susan
Resumen
We evaluated predictors and outcomes of Mycobacterium tuberculosis bacteremia among participants undergoing baseline mycobacterial blood culture in the ACTG A5221 STRIDE study, a randomized clinical trial comparing earlier with later ART among HIV-infected patients suspected of having tuberculosis with CD4-positive T-lymphocyte counts (CD4 counts) <250 cells/mm(3). We conducted a secondary analysis comparing participants with respect to presence or absence of M. tuberculosis bacteremia.